Clozapine-Induced Cardiovascular Side Effects and Autonomic Dysfunction: A Systematic Review
Background: Clozapine is the antipsychotic of choice for treatment-resistant schizophrenia and has minimal risk for extrapyramidal symptoms. Therapeutic benefits, however, are accompanied by a myriad of cardiometabolic side-effects. The specific reasons for clozapine's high propensity to cause...
Main Authors: | Jessica W. Y. Yuen, David D. Kim, Ric M. Procyshyn, Randall F. White, William G. Honer, Alasdair M. Barr |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-04-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fnins.2018.00203/full |
Similar Items
-
Effective and underprescribed: what about clozapine?
by: Helge H.O. Müller
Published: (2017-10-01) -
Agranulocytosis and cardiac toxicity - serious side effects of clozapine
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019-09-01) -
Dealing With Clozapine-Induced Sialorrhea
by: J. Sá Couto, et al.
Published: (2022-06-01) -
Risks and benefits of rapid clozapine titration
by: Jeannie D. Lochhead, et al.
Published: (2016-05-01) -
Clozapine: A special case of an atypical antipsychotic
by: Elina Marinho
Published: (2024-04-01)